ImmunologyMolecular Therapy AdvancesPeer-reviewed
CD19xCD3 bispecific T cell engager treatment induces remission in experimental pemphigoid disease
Natalie Groß, Alexander Jochimsen, Sören Dräger…·Matthias Peipp
The paper tests a CD19xCD3 bispecific T cell engager in a mouse model of pemphigoid disease and finds it induces remission in 45% of treated mice.
DOI 10.1016/j.omta.2026.201825